MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$23,388K
Net Income
-$4,446K
Net Profit Margin
-19.01%
EPS
-$0.08
Unit: Thousand (K) dollars
Revenue Breakdown
Surgical Glaucoma
Dry Eye
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
23,388
19,698
20,385
19,906
Cost of goods sold
2,014
2,720
2,597
2,709
Gross profit
21,374
16,978
17,788
17,197
Research and development
2,512
2,546
2,437
3,352
Selling, general and administrative
22,750
26,845
19,019
21,750
Total operating expenses
25,262
29,391
21,456
25,102
Loss from operations
-3,888
-12,413
-3,668
-7,905
Investment income
678
741
834
965
Interest expense
1,290
1,268
1,289
1,306
Loss on debt extinguishment
-
-
0
0
Other income (expense), net
82
-29
-31
-2
Loss before income taxes
-4,418
-12,969
-4,154
-8,248
Provision for income taxes
28
11
8
-79
Net loss and comprehensive loss
-4,446
-12,980
-4,162
-8,169
Basic EPS
-0.08
-0.24
-0.078
-0.16
Diluted EPS
-0.08
-0.24
-0.078
-0.16
Basic Average Shares
54,505,792
53,943,085
53,103,929
52,377,805
Diluted Average Shares
54,505,792
53,943,085
53,103,929
52,377,805
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss and
comprehensive loss
-$4,446K
(62.77%↑ Y/Y)
Surgical Glaucoma
$20,713K
(7.71%↑ Y/Y)
Dry Eye
$2,675K
(703.30%↑ Y/Y)
Loss before income
taxes
-$4,418K
(62.88%↑ Y/Y)
Provision for income taxes
$28K
(-30.00%↓ Y/Y)
Investment income
$678K
(-33.92%↓ Y/Y)
Other income
(expense), net
$82K
(241.67%↑ Y/Y)
Revenue
$23,388K
(19.55%↑ Y/Y)
Loss from operations
-$3,888K
(66.68%↑ Y/Y)
Interest expense
$1,290K
(0.47%↑ Y/Y)
Gross profit
$21,374K
(28.86%↑ Y/Y)
Cost of goods sold
$2,014K
(-32.35%↓ Y/Y)
Total operating
expenses
$25,262K
(-10.59%↓ Y/Y)
Selling, general and
administrative
$22,750K
(-4.68%↓ Y/Y)
Research and development
$2,512K
(-42.74%↓ Y/Y)
Buy us a coffee
Sight Sciences, Inc. (SGHT)
Sight Sciences, Inc. (SGHT)